Skip to main content
Watch Insiders
SYRE filings

Corporate insider profile

Scott L Burrows Filing Activity

Latest reported as Chief Financial Officer of Spyre Therapeutics, Inc. (SYRE).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,732,061.75
Latest transaction
Jun 25, 2026

Affiliated corporations

Reported company relationships

SYRELatest reported

Spyre Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 25, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale15,000$87.13$1,307,000
Jun 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale7,500$71.06$532,937
May 1, 2026Spyre Therapeutics, Inc. (SYRE)Chief Financial OfficerSale12,500$71.37$892,125